> Do Biologics Weaken the Immune System? | BiologicHealthPlus>

Do Biologics Weaken the Immune System?

How biologics affect immunity, infection risk, and what precautions to take

Quick Answer

Biologics do not "shut off" the immune system the way high-dose steroids do. Instead, they selectively modulate specific inflammatory pathways — blocking TNF-alpha, IL-17, IL-23, or JAK enzymes — while leaving much of the immune system intact. However, this selective suppression does increase the risk of certain infections and requires pre-treatment screening and monitoring.

How Biologics Differ from General Immunosuppression

Traditional immunosuppressants like prednisone or high-dose corticosteroids broadly suppress the immune system, leaving patients vulnerable to a wide range of infections and other complications. Biologics take a more targeted approach — they interfere with one specific protein or receptor that drives inflammation in autoimmune disease.

The result is reduced autoimmune inflammation with a more limited impact on overall immune function. However, because the targeted pathways also play roles in defending against certain pathogens, some infection risk is still elevated.

Infection Risks by Drug Class

TNF Inhibitors

Increase risk of bacterial infections, TB reactivation, and invasive fungal infections. Require TB screening before starting. Serious infections occur in a minority of patients.

JAK Inhibitors

Broadest immunosuppression profile among targeted therapies. Elevated risk of herpes zoster (shingles), serious infections, and opportunistic infections. Shingrix vaccination strongly recommended.

IL-23 / IL-17 Inhibitors

Generally lower infection risk than TNF inhibitors. IL-17 inhibition increases oral candidiasis risk. Use with caution in patients with active IBD (IL-17 inhibitors).

IL-4/IL-13 (Dupixent)

Targeted type 2 pathway blockade — limited impact on innate immunity. Lower infection risk profile than most biologics. Conjunctivitis is the most common adverse effect.

Gut-Selective (Entyvio)

Blocks gut-specific integrin — minimal systemic immunosuppression. Infection risk profile is notably favorable compared to systemic immunosuppressants.

Practical Precautions for Patients on Biologics

For minor infections like a common cold, you generally do not need to stop your biologic — but you should inform your prescriber. For serious infections (high fever, hospitalization, deep tissue infection), your prescriber will likely advise holding your biologic until the infection is fully treated. Never stop a biologic without medical guidance.
Yes. Antibiotics can generally be taken while on a biologic. However, always inform your prescribing specialist about any antibiotic course you are taking, as some serious infections may require temporarily holding your biologic. BiologicHealthPlus pharmacists can also check for any relevant interactions.
TNF inhibitors and JAK inhibitors carry black box warnings noting an increased risk of lymphoma and other malignancies, though the absolute risk in individual patients is low. The risk must be weighed against the significant benefits of disease control. IL-23 and IL-17 inhibitors, and Dupixent, do not carry malignancy black box warnings. Discuss your personal risk factors with your prescriber.

💬 Questions About Your Specific Biologic's Safety Profile?

BiologicHealthPlus pharmacists are available 24/7 to discuss your medication's specific infection risks, monitoring requirements, and precautions.

Talk to a Pharmacist →

Related: Vaccines and biologics · Side effects guide · Biologics and surgery

📚 Sources & Further Reading

Content developed with reference to leading health organizations, peer-reviewed research, and FDA prescribing information.

🔗
Immunocompromised PatientsCDC
🔗
ImmunosuppressionWikipedia
🔗
Infection Risk BiologicsNIH/NCBI
🔗
Drug Safety UpdatesACR

Medical Disclaimer: Educational content reviewed by the BiologicHealthPlus Clinical Team. Consult your healthcare provider for personalized advice. Last reviewed: August 2026.

Medical Disclaimer: Educational information only. Discuss your specific risks with your prescribing physician. Last updated: July 2026.